COVID-19 Outbreak: An Overview

Marco Ciotti(Policlinico Tor Vergata), Silvia Angeletti(Università Campus Bio-Medico), Marilena Minieri(University of Rome Tor Vergata), Marta Giovannetti(Fundação Oswaldo Cruz), Domenico Benvenuto(Università Campus Bio-Medico), Stefano Pascarella(Sapienza University of Rome), Caterina Sagnelli(University of Campania "Luigi Vanvitelli"), Martina Bianchi(Sapienza University of Rome), Sergio Bernardini(University of Rome Tor Vergata), Massimo Ciccozzi(Università Campus Bio-Medico)
Chemotherapy
January 1, 2019
Cited by 446Open Access
Full Text

Abstract

BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures.


Related Papers

No related papers found

Powered by citation graph analysis